Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 20, 2009Expert Opinion on Pharmacotherapy

Adipokines in the treatment of diabetes mellitus and obesity

View Full Paper
Ask AI
Bookmark
Share

Authors

VCVictoria CatalánGeneral / Preventive / LipidsJGJavier Gómez‐AmbrosiInstituto de Salud Carlos IIIARAmaia Rodrı́guezUniversitat Pompeu Fabra

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Catalán et al. (2009) studied this question.

synapsesocial.com/papers/6aa714a15069cd445b81292bhttps://doi.org/10.1517/14656560802618811
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Visceral adipose tissue-derived serine protease inhibitor: A unique insulin-sensitizing adipocytokine in obesity2005 · 728 citations
  2. 2Osteopontin Expression in Human and Murine Obesity: Extensive Local Up-Regulation in Adipose Tissue but Minimal Systemic Alterations2007 · 162 citations
  3. 3Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.1994 · 962 citations
  4. 4Bariatric Surgery2004 · 6,818 citations
  5. 5A 25 kDa α<sub>2</sub>‐microglobulin‐related protein is a component of the 125 kDa form of human gelatinase1992 · 229 citations